Ibandronic acid Accord - direct healthcare professional communication (DHPC)

ibandronic acid

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Ibandronic acid Accord solution for injection 3 mg/3ml in pre-filled syringe (ibandronic acid) - product packaging issues (injection needle having a shorter expiration date than the product shelf-life)

Dissemination date: 05/12/2024

Key facts

• Medicine name:
  Ibandronic acid Accord
• Active substance:
  ibandronic acid
• Therapeutic area (MeSH):
  • Wounds and Injuries
  • Breast Diseases
  • Neoplastic Processes
  • Calcium Metabolism Disorders
  • Water-Electrolyte Imbalance
• DHPC type:
  Quality defect
• Human ATC codes:
  M05BA06
• Dissemination date:
  05/12/2024